Actualización del manejo de la cetoacidosis diabética según las guías ADA 2024–2026: una scoping review de la evidencia reciente

Revista Multidisciplinar Epistemología de las Ciencias 2026 Open access

Read full text
Authors: José Francisco Miranda Bajaña, Byron Andrés Chamba Lapo, Kevin Hair Taipe Mayorga, Marilyn Denise Guevara Acurio, Edison Patricio Ninabanda Inca
DOI: 10.71112/70cncx27
Cited by: 0
References: 26

Abstract

The ADA guidelines (2024-2026) have updated the approach to diabetic ketoacidosis (DKA). While the foundation remains the clinical triad of hyperglycemia, ketonuria, and acidosis, β-hydroxybutyrate now plays a key role as the primary marker. Regarding treatment, there are two key changes: the preference for balanced crystalloids over saline (to avoid hyperchloremic acidosis) and the endorsement of subcutaneous insulin for mild to moderate cases, facilitating management outside the ICU. Additionally, technology such as continuous glucose monitoring (CGM) and effective patient education are the best tools we have today to prevent recurrences and complications.

Fields of Study & Subjects

Diabetes Management and Research Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Treatment and Management

Publication details

Journal / source
Revista Multidisciplinar Epistemología de las Ciencias
Volume
3
Issue
1
Pages
1115–1135
Publication date
10 February 2026
Language
EN